Nutra Pharma Corp (NPHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -794 | -427 | -1,393 | -1,150 | -872 |
| Depreciation Amortization | 117 | 59 | 235 | 192 | 140 |
| Accounts receivable | 0 | 0 | -1 | 0 | 0 |
| Accounts payable and accrued liabilities | 108 | 64 | 36 | 25 | 16 |
| Other Working Capital | 273 | 136 | 342 | 371 | 256 |
| Other Operating Activity | 32 | -4 | 232 | 199 | 180 |
| Operating Cash Flow | $-265 | $-171 | $-550 | $-364 | $-280 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 84 | N/A | N/A |
| Other Investing Activity | -1 | 0 | 34 | 34 | 0 |
| Investing Cash Flow | $-1 | $N/A | $117 | $34 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 432 | 306 | 727 | 528 | 364 |
| Debt Repayment | -236 | -135 | -476 | -380 | -201 |
| Other Financing Activity | 70 | 0 | 182 | 182 | 116 |
| Financing Cash Flow | $266 | $171 | $433 | $330 | $279 |
| Net Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -265 | -171 | -550 | -364 | -280 |
| Free Cash Flow | -265 | -171 | -550 | -364 | -280 |